ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC007421.1 | | | | | | | Tissue enhanced |
AC022431.2 | Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. | | | | | | Tissue enhanced |
AC026703.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
AC136297.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ACOT4 | Acyl-CoA thioesterase 4 | Enzymes
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AIF1L | Allograft inflammatory factor 1-like | | | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ASPA | Aspartoacylase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ASPDH | Aspartate dehydrogenase domain containing | Enzymes
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | | | | Tissue enhanced |
B3GNT4 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes
| | | | | Tissue enhanced |
BICC1 | Bicaudal C homolog 1 (Drosophila) | Disease related genes
| | | | | Tissue enhanced |
C18orf56 | Chromosome 18 open reading frame 56 | | | | | | Tissue enhanced |
C19orf77 | Chromosome 19 open reading frame 77 | Predicted membrane proteins
| | | | | Tissue enhanced |
C21orf62 | Chromosome 21 open reading frame 62 | Predicted secreted proteins
| | | | | Tissue enhanced |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CALCR | Calcitonin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | | | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLNK | Cytokine-dependent hematopoietic cell linker | | | | | | Tissue enhanced |
CNTD2 | Cyclin N-terminal domain containing 2 | | | | | | Tissue enhanced |
COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DEFB1 | Defensin, beta 1 | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
DMRT2 | Doublesex and mab-3 related transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | | | | | | Tissue enhanced |
EGF | Epidermal growth factor | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ENAM | Enamelin | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ENPP6 | Ectonucleotide pyrophosphatase/phosphodiesterase 6 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ESM1 | Endothelial cell-specific molecule 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESRRB | Estrogen-related receptor beta | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |